Expression profile of altered long non-coding RNAs in patients with HBV-associated hepatocellular carcinoma

Abstract

In China, hepatitis B virus (HBV) infection is the major cause of hepatocellular carcinoma (HCC), which is called HBV-related HCC (HBV-HCC), but the pathogenesis has not been clearly elucidated. Long non-coding RNAs (lncRNAs) have been paid increasing attention to, as an important regulatory molecule involved in many biological processes, as well as a variety of diseases. This study examined lncRNA that might play an important role in HBV-HCC pathogenesis by conducting lncRNA and mRNA profile comparison between HBV-HCC and normal liver tissues. The differentially expressed lncRNA and mRNA profiles between HBV-HCC and normal liver tissues were analyzed by microarrays. The potential protein-encoding gene regulated by lncRNA, and the biological function (gene ontology, pathway analysis) of the target gene were investigated. The results showed that the expression levels of lncRNA and mRNA in HBV-HCC tissues were different from those in normal liver tissues. As compared with normal liver tissue, 837 (4.30%) lncRNAs exhibited more than two-fold change (P<0.05); 325 were up-regulated, and 512 were down-regulated; 991 (5.70%) mRNAs exhibited more than 2-fold change (P<0.05); 733 were up-regulated and 258 were down-regulated in HBV-HCC tissue. Besides, there were 7 lncRNAs with above 10-fold elevation, 6 lncRNAs with above 10-fold decrease, 18 mRNAs with above 10-fold elevation and 11 mRNAs with above 10-fold decrease. 444 (53.05%) lncRNAs had their corresponding mRNAs, some of which were adjacent to lncRNAs. The biological analysis showed that the target gene of differentially expressed lncRNAs took part in the important biological regulatory function. Target gene-related pathway analysis revealed the pathways in carcinoma and mitogen-activated protein kinase (MAPK) signaling pathways significantly changed in the HBV-HCC tissues as compared with normal liver tissues (P<0.05). It was suggested that as compared with normal liver tissues, the expression of lncRNAs in HBV-HCC tissues changed significantly, and lncRNAs played a key role in the pathogenesis of HBV-HCC probably by mainly regulating the carcinoma-related signaling pathway and MAPK signaling pathways.

Keywords

long non-coding RNA / gene expression / hepatocellular carcinoma / hepatitis B virus

References

[1] MaluccioM., CoveyA.. Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J Clin, 2012, 62(6): 394-399

[2] WhittakerS., MaraisR., ZhuA.X.. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene, 2010, 29(36): 4989-5005

[3] FaraziP.A., DePinhoR.A.. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer, 2006, 6(9): 674-687

[4] BrosnanC.A., VoinnetO.. The long and the short of noncoding RNAs. Curr Opin Cell Biol, 2009, 21(3): 416-425

[5] MattickJ.S., MakuninI.V.. Non-coding RNA. Hum Mol Genet, 2006, 15(Spec1): R17-29

[6] ChenL.L., CarmichaelG.G.. Decoding the function of nuclear long non-coding RNAs. Curr Opin Cell Biol, 2010, 22(3): 357-364

[7] PontingC.P., OliverP.L., ReikW.. Evolution and functions of long noncoding RNAs. Cell, 2009, 136(4): 629-641

[8] HuarteM., RinnJ.L.. Large non-coding RNAs: missing links in cancer. Hum Mol Genet, 2010, 19R2: R152-161

[9] JiaH., OsakM., BoguG.K., et al.. Genome-wide computational identification and manual annotation of human long noncoding RNA genes. RNA, 2010, 16(8): 1478-1487

[10] TaferH., HofackerI.L.. RNAplex: a fast tool for RNA-RNA interaction search. Bioinformatics, 2008, 24(22): 2657-2663

[11] PanzittK., TschernatschM.M., GuellyC., et al.. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology, 2007, 132(1): 330-342

[12] OzkanH., ErdalH., KocakE., et al.. Diagnostic and prognostic role of serum glypican 3 in patients with hepatocellular carcinoma. J Clin Lab Anal, 2011, 25(5): 350-353

[13] HoM., KimH.. Glypican-3: a new target for cancer immunotherapy. Eur J Cancer, 2011, 47(3): 333-338

[14] NasoM.F., LiangB., HuangC.C., et al.. Dermokine: an extensively differentially spliced gene expressed in epithelial cells. J Invest Dermatol, 2007, 127(7): 1622-1631

[15] LeeE.J., JoM., RhoS.B., et al.. Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin. Int J Cancer, 2009, 124(2): 287-297

[16] YangZ.R., DongW.G., LeiX.F., et al.. Overexpression of Dickkopf-3 induces apoptosis through mitochondrial pathway in human colon cancer. World J Gastroenterol, 2012, 18(14): 1590-1601

[17] ChenC.H., ChuangS.M., YangM.F., et al.. A novel function of YWHAZ/beta-catenin axis in promoting epithelial-mesenchymal transition and lung cancer metastasis. Mol Cancer Res, 2012, 10(10): 1319-1331

[18] SaadS., StannersS.R., YongR., et al.. Notch mediated epithelial to mesenchymal transformation is associated with increased expression of the Snail transcription factor. Int J Biochem Cell Biol, 2010, 42(7): 1115-1122

[19] ChuaysriC., ThuwajitP., PaupairojA., et al.. Alpha-smooth muscle actin-positive fibroblasts promote biliary cell proliferation and correlate with poor survival in cholangiocarcinoma. Oncol Rep, 2009, 21(4): 957-969

[20] LeeJ.T.. Lessons from X-chromosome inactivation: long ncRNA as guides and tethers to the epigenome. Genes Dev, 2009, 23(16): 1831-1842

[21] MercerT.R., DingerM.E., MattickJ.S.. Long non-coding RNAs: insights into functions. Nat Rev Genet, 2009, 10(3): 155-159

[22] GibbE.A., BrownC.J., LamW.L.. The functional role of long non-coding RNA in human carcinomas. Mol Cancer, 2011, 10: 38

[23] LaiJ.P., OseiniA.M., MoserC.D., et al.. The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation. Hepatology, 2010, 52(5): 1680-1689

[24] KhalilA.M., GuttmanM., HuarteM., et al.. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci USA, 2009, 106(28): 11 667-11 672